rs116870693

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_002458.3(MUC5B):​c.9010G>A​(p.Ala3004Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0293 in 1,612,868 control chromosomes in the GnomAD database, including 287 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.025 ( 10 hom., cov: 29)
Exomes 𝑓: 0.030 ( 277 hom. )

Consequence

MUC5B
NM_002458.3 missense

Scores

17

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.876

Publications

7 publications found
Variant links:
Genes affected
MUC5B (HGNC:7516): (mucin 5B, oligomeric mucus/gel-forming) This gene encodes a member of the mucin family of proteins, which are highly glycosylated macromolecular components of mucus secretions. This family member is the major gel-forming mucin in mucus. It is a major contributor to the lubricating and viscoelastic properties of whole saliva, normal lung mucus and cervical mucus. This gene has been found to be up-regulated in some human diseases, including sinus mucosa of chronic rhinosinusitis (CRS), CRS with nasal polyposis, chronic obstructive pulmonary disease (COPD) and H. pylori-associated gastric disease, and it may be involved in the pathogenesis of these diseases. [provided by RefSeq, Jul 2010]
MUC5B-AS1 (HGNC:53936): (MUC5B antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0030438304).
BP6
Variant 11-1245890-G-A is Benign according to our data. Variant chr11-1245890-G-A is described in ClinVar as Likely_benign. ClinVar VariationId is 403185.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0247 (3739/151410) while in subpopulation NFE AF = 0.0324 (2203/67902). AF 95% confidence interval is 0.0313. There are 10 homozygotes in GnomAd4. There are 1860 alleles in the male GnomAd4 subpopulation. Median coverage is 29. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 10 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MUC5BNM_002458.3 linkc.9010G>A p.Ala3004Thr missense_variant Exon 31 of 49 ENST00000529681.5 NP_002449.2 Q9HC84
MUC5B-AS1NR_157183.1 linkn.57-3252C>T intron_variant Intron 1 of 1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MUC5BENST00000529681.5 linkc.9010G>A p.Ala3004Thr missense_variant Exon 31 of 49 5 NM_002458.3 ENSP00000436812.1 Q9HC84
MUC5B-AS1ENST00000532061.2 linkn.57-3252C>T intron_variant Intron 1 of 1 5

Frequencies

GnomAD3 genomes
AF:
0.0247
AC:
3740
AN:
151290
Hom.:
10
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.0126
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.00742
Gnomad ASJ
AF:
0.0277
Gnomad EAS
AF:
0.000782
Gnomad SAS
AF:
0.00833
Gnomad FIN
AF:
0.0684
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0324
Gnomad OTH
AF:
0.0216
GnomAD2 exomes
AF:
0.0263
AC:
6558
AN:
249208
AF XY:
0.0261
show subpopulations
Gnomad AFR exome
AF:
0.0148
Gnomad AMR exome
AF:
0.00519
Gnomad ASJ exome
AF:
0.0285
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0730
Gnomad NFE exome
AF:
0.0340
Gnomad OTH exome
AF:
0.0273
GnomAD4 exome
AF:
0.0298
AC:
43529
AN:
1461458
Hom.:
277
Cov.:
66
AF XY:
0.0292
AC XY:
21209
AN XY:
727038
show subpopulations
African (AFR)
AF:
0.0112
AC:
376
AN:
33434
American (AMR)
AF:
0.00570
AC:
255
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
0.0291
AC:
761
AN:
26122
East Asian (EAS)
AF:
0.000126
AC:
5
AN:
39700
South Asian (SAS)
AF:
0.00955
AC:
824
AN:
86246
European-Finnish (FIN)
AF:
0.0719
AC:
3837
AN:
53330
Middle Eastern (MID)
AF:
0.00468
AC:
27
AN:
5766
European-Non Finnish (NFE)
AF:
0.0322
AC:
35805
AN:
1111786
Other (OTH)
AF:
0.0272
AC:
1639
AN:
60362
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.557
Heterozygous variant carriers
0
2782
5564
8345
11127
13909
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1332
2664
3996
5328
6660
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0247
AC:
3739
AN:
151410
Hom.:
10
Cov.:
29
AF XY:
0.0251
AC XY:
1860
AN XY:
73966
show subpopulations
African (AFR)
AF:
0.0126
AC:
516
AN:
41056
American (AMR)
AF:
0.00741
AC:
113
AN:
15240
Ashkenazi Jewish (ASJ)
AF:
0.0277
AC:
96
AN:
3460
East Asian (EAS)
AF:
0.000783
AC:
4
AN:
5106
South Asian (SAS)
AF:
0.00833
AC:
40
AN:
4800
European-Finnish (FIN)
AF:
0.0684
AC:
721
AN:
10540
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.0324
AC:
2203
AN:
67902
Other (OTH)
AF:
0.0214
AC:
45
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.587
Heterozygous variant carriers
0
196
392
588
784
980
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
44
88
132
176
220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0222
Hom.:
12
ESP6500AA
AF:
0.0159
AC:
68
ESP6500EA
AF:
0.0334
AC:
283
ExAC
AF:
0.0273
AC:
3312

ClinVar

Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.068
BayesDel_addAF
Benign
-0.75
T
BayesDel_noAF
Benign
-0.82
CADD
Benign
1.0
DANN
Benign
0.59
DEOGEN2
Benign
0.017
T
Eigen
Benign
-1.4
Eigen_PC
Benign
-1.5
FATHMM_MKL
Benign
0.0076
N
LIST_S2
Benign
0.10
T
MetaRNN
Benign
0.0030
T
MetaSVM
Benign
-0.99
T
MutationAssessor
Benign
0.69
N
PhyloP100
-0.88
PrimateAI
Benign
0.33
T
PROVEAN
Benign
-0.43
N
REVEL
Benign
0.012
Sift
Benign
0.26
T
Vest4
0.087
ClinPred
0.00013
T
GERP RS
-1.2
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.2
Varity_R
0.026
gMVP
0.17
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs116870693; hg19: chr11-1267120; COSMIC: COSV71593744; API